CA
NZ
UK
AU
IND
US
• Virax Biolabs has drawn renewed market attention after a share-price slide that reflects fresh pressure on small-capitalisation biotech names.
• VisionWave Holdings has drawn heightened market attention after a share-price slide that has tested sentiment around this defense-and-advanced-technology name.
• Nexentis Technologies has drawn market attention after a share-price slide that has tested small-cap technology sentiment.
• Orchestra BioMed has drawn heightened market attention following share-price weakness that has placed the clinical-stage biotech under closer investor examination.
• Protara Therapeutics has drawn heightened market attention after a share-price slide that lines up with a fresh check on biotech sentiment.
• Portfolio company MediGuide International launched a new API-first enterprise digital platform.
• Fiscal 2026 net sales were $190.5 million, down 14.3% year over year, or 5.4% when adjusted for prior-year order timing.
• A shareholder rights law firm is investigating potential securities law violations by company officers and directors.
• AVX shares rose 0.67% intraday to $5.23, following a sharp intraday pullback from an earlier high near $6.03.
• The company filed to register up to 22.3 million Class B ordinary shares for offer and sale by a selling shareholder.
Please wait processing your request...